期刊文献+

癌组织中S100A2基因的表达及其临床病理学意义 被引量:5

Expression of S100A2 gene and clinicopathological implication in gastric carcinoma
暂未订购
导出
摘要 目的检测胃癌组织中S100A2基因的mRNA和蛋白表达水平,分析S100A2基因在胃癌发生、发展过程中的作用机制。方法应用免疫组化、Western Blotting技术、RT-PCR技术检测胃癌组织中S100A2mRNA、蛋白表达水平的改变。结果 S100A2蛋白定位于胃黏膜上皮细胞的胞浆及胞核,胃癌组织中S100A2mRNA、蛋白表达下调,低分化胃癌与淋巴结转移胃癌S100A2表达降低最明显。结论胃癌组织S100A2蛋白、mRNA表达降低,且其表达与胃癌分化程度和淋巴结转移相关。 【Objective】To evaluate the possible role mechanism of S100A2 gene in the process of carcinogenesis and development in stomach,the levels of mRNA and protein of S100A2 gene were detected.【Methods】The expression state of mRNA and protein of S100A2 gene were analyzed by RT-PCR,S-P immunohistochemical assay and Western blotting respectively in gastric carcinoma.【Results】The S100A2 staining was located on the nuclear membrane and in the cytoplasm.The levels of S100A2 mRNA and protein in gastric carcinoma were significantly lower than that in normal gastric mucosa,and the expression of S100A2 gene was the lowest in the poorly differentiated gastric carcinoma and gastric carcinoma with lymph metastasis.【Conclusions】The expression of S100A2 gene,which was correlated with differentiation degree of gastric carcinoma and lymph metastasis,was significantly lower in gastric carcinoma than that in normal gastric mucosa.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2012年第22期52-56,共5页 China Journal of Modern Medicine
关键词 胃癌 S100A2基因 分化程度 淋巴结转移 gastric carcinoma S100A2 gene degree of differentiation lymph metastasis
  • 相关文献

参考文献1

二级参考文献4

共引文献19

同被引文献51

  • 1冯旺琴,崔竹梅,刘芝华,李玉军.S100A8和S100A9在子宫颈鳞癌组织中的表达[J].现代肿瘤医学,2008,16(11):1969-1972. 被引量:7
  • 2廖秋林,张卫云,张宏斌,崔华娟,陈炳旭,张伟,陈晓东.鼻咽癌患者血清sICAM-1和SAA1及HSP70检测临床意义分析[J].中华肿瘤防治杂志,2013,20(2):110-112. 被引量:16
  • 3汪必成,刘志苏.钙结合蛋白S100A2在肝癌中的表达及与肿瘤细胞增殖的关系[J].中华实验外科杂志,2007,24(7):790-791. 被引量:5
  • 4Moore BW. A soluble protein characteristic of nervous system[ J]. Biochem Biophys Res Commun, 1965,19 (6) :739.
  • 5Ohuchida K, Mizumoto K, Miyasaka Y, et al. Over - expression of S100A2 calcium- binding protein predicts response to pancreatec- tomy for pancreatic cancer [ J ]. Gastroenterology, 2009, 137 ( 2 ) : 558 - 568.
  • 6Ane Kongsgaard Rud, Marius Lund - Iversen, Gisle Berge, et al. Expression of S100A4, ephrin- A1 and osteopontin in non -small cell lung cancer[ J]. BMC Cancer,2012,12:333.
  • 7Prinetti A, Cao T, llluzzi G, et al. A glycosphingolipid/caveolin - 1 singnaling complex inhibits motility of human ovarian carcinoma cell[J]. J Biol Chem,2011,286(47) :40900 -40910.
  • 8Berge G, Pettersen S, Grottcrod I, et al. Osteopontin - an important downstream effector of S100A4 - mediated invasion and metastasis [J]. Cancer,2011,129 (4) :780 -790.
  • 9Kilanczyk E, Graczyk A, Ostrowska H, et al. $100A6 is transcrip- tionally regulated by [3 -catenin and interacts with a novel target, lamin A/C ,in colorectal cancer cells[ J]. Cell Calcium,2012,51 : 470 - 477.
  • 10Nedjadi T,Kitteringham N,Campbell F,et al. S100A6 binds to an- nexin2 in pancreatic cancer cells and promotes pancreatic cancer cell motility[J]. Br J Cancer,2009,101 (7) :1145 - 1154.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部